Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 83: 746-752, 1997;
8750-7587/97 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oostenbrug, G. S.
Right arrow Articles by Hornstra, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oostenbrug, G. S.
Right arrow Articles by Hornstra, G.

Journal of Applied Physiology
Vol. 83, No. 3, pp. 746-752, September 1997
EXERCISE AND MUSCLE

Exercise performance, red blood cell deformability, and lipid peroxidation: effects of fish oil and vitamin E

G. S. Oostenbrug, R. P. Mensink, M. R. Hardeman, T. De Vries, F. Brouns, and G. Hornstra

Department of Human Biology, Maastricht University, 6200 MD Maastricht; and Department of Internal Medicine, Academic Medical Center, 1105 AZ Amsterdam, The Netherlands

ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
ACKNOWLEDGEMENTS
FOOTNOTES
REFERENCES


ABSTRACT

Oostenbrug, G. S., R. P. Mensink, M. R. Hardeman, T. De Vries, F. Brouns, and G. Hornstra. Exercise performance, red blood cell deformability, and lipid peroxidation: effects of fish oil and vitamin E. J. Appl. Physiol. 83(3): 746-752, 1997.---Previous studies have indicated that fish oil supplementation increases red blood cell (RBC) deformability, which may improve exercise performance. Exercise alone, or in combination with an increase in fatty acid unsaturation, however, may enhance lipid peroxidation. Effects of a bicycle time trial of ~1 h on RBC characteristics and lipid peroxidation were, therefore, studied in 24 trained cyclists. After 3 wk of fish oil supplementation (6 g/day), without or with vitamin E (300 IU/day), trial performance, RBC characteristics, and lipid peroxidation were measured again. RBC deformability appeared to decrease during endurance exercise. After correction for hemoconcentration, plasma total tocopherol concentrations decreased by 0.77 µmol/l (P = 0.012) or 2.9% and carotenoid concentrations by 0.08 µmol/l (P = 0.0008) or 4.5%. Endurance exercise did not affect the lag time and rate of in vitro oxidation of low-density lipoproteins (LDLs), but the maximum amount of conjugated dienes formed decreased by 2.1 ± 1.0 µmol/mmol LDL cholesterol (P = 0.042) or 1.2%. Fish oil supplementation with and without vitamin E did not affect RBC characteristics or exercise performance. Both supplements decreased the rate of LDL oxidation, and fish oil supplementation with vitamin E delayed oxidation. The amount of dienes, however, was not affected. The supplements also did not change effects of exercise. We conclude that the changes observed during endurance exercise may indicate increased oxidative stress, but further research is necessary to confirm this. Fish oil supplementation does not improve endurance performance, but it also does not cause or augment changes in antioxidant levels or LDL oxidation during exercise.

oxidative stress; diet; unsaturated fatty acids; antioxidants


INTRODUCTION

THE DEFORMABILITY OF RED BLOOD CELLS (RBCs) decreases during exercise (8, 29), which may impede blood flow through various regions of the microcirculation (23). The reduced deformability may, at least partly, be due to increased production of free radicals during exercise, which induces peroxidation of unsaturated fatty acids in membrane phospholipids and polymerization of membrane proteins (26). Several studies have also indicated that dietary fish oils increase the deformability of RBC as a result of the incorporation of (n-3) fatty acids in the membrane (4, 28) and facilitate the transport of RBC through the microcirculation (3). Therefore, fish oil supplementation may enhance oxygen supply to muscles and improve exercise performance.

However, incorporation of the highly unsaturated fatty acids in membranes may increase the membranes' susceptibility to lipid peroxidation, especially in combination with exercise. Previously, we (21) have reported that the susceptibility to oxidation of low-density lipoproteins (LDLs) was increased by 20% after fish oil supplementation and that this potentially unbeneficial effect could be counteracted by the antioxidant vitamin E.

Therefore, we have investigated the effects of exercise and fish oil supplementation, with or without vitamin E, on the deformability of RBCs and lipid peroxidation and the effects of the supplements on exercise performance.


METHODS

Subjects and Study Design

Twenty-four apparently healthy, well-trained male cyclists (aged 19-42 yr) entered the study between January 11 and 26, 1995. Written informed consent was received from each subject, and prior approval for the study was obtained from the Medical Ethics Committee of Maastricht University. Participants were asked to abstain from intense physical activity for 36 h before the measurements and were instructed not to use any antioxidant supplements during and 2 wk preceding the study. At the start of the study, maximal workload capacity (Wmax) of each participant was determined. Four to 7 days later, the subjects performed an endurance exercise test on a cycle ergometer. For the next 3 wk, eight subjects received a placebo supplement (P group), eight subjects received a fish oil supplement (F group; 6 g of fish oil daily), and eight subjects received the fish oil supplement together with vitamin E (FE group; Ephynal 300, 300 IU DL-alpha -tocopherol acetate daily). Data from previous studies (11, 12, 14, 21, 29) indicated that eight subjects in each group were sufficient to detect, with a power of 80%, a difference in change between the experimental groups for RBC deformability of <2%, for endurance performance of 7%, and for LDL oxidation in vitro of 10%. The three groups were stratified for Wmax, and, as far as possible, one subject from each group was tested on the same day. At the end of the study, exercise testing procedures were repeated.

Placebo capsules, containing microcrystalline cellulose, were supplied by the pharmacy of the Academic Hospital Maastricht (Maastricht, The Netherlands). The fish oil capsules (Fish-EPA) were a generous gift from Orthica (Weesp, The Netherlands), and Ephynal 300 capsules were from Hoffmann-La Roche (Basel, Switzerland). The fish oil capsules contained (wt/wt) 17.6% eicosapentaenoic acid [(EPA) C20:5 (n-3)] and 12.5% docosahexaenoic acid [(DHA) C22:6 (n-3)], and only 0.12% vitamin E (0.01% delta -tocopherol, 0.03% beta +gamma -tocopherol, 0.08% alpha -tocopherol), as analyzed by gas chromatography and high-performance liquid chromatography (HPLC), respectively.

Exercise Performance Protocols

Wmax test. Wmax was determined during an incremental cycle ergometer test with 3-min intervals (16). Oxygen uptake was measured continuously (Oxycon Delta, Mijnhard, The Netherlands). Wmax of each subject, as measured the week before supplementation started, was used for both endurance exercise tests. The second Wmax test, performed after 15-17 days of supplementation, was used to detect changes in Wmax and plasma lactate concentrations due to the supplements.

Endurance exercise test. Before and after the 3-wk period of supplementation, subjects were asked to perform a prefixed absolute workload on a linearly functioning cycle ergometer (Lode Excalibur Sport, Lode, Groningen, The Netherlands), in as little time as possible. The workload was based on 70% of the Wmax of each subject, and the workload output depended directly on the pedaling frequency. During the test, subjects were only informed about the cumulative achieved amount of work, as displayed by a 0-100% indicator of the total workload. Time as well as pedaling frequency were blinded to the subjects. Subjects were allowed to drink tap water ad libitum. The time needed to complete the test was used as a measure of physical performance. This new validated endurance exercise test, resembling a time trial of ~1 h, has been described in detail by Jeukendrup et al. (14).

Blood Sampling

Wmax test. At the end of each workload step, antecubital blood was collected via an intravenous Teflon catheter (Baxter, Utrecht, The Netherlands) in Na2EDTA · 2H2O (final concentration 2 g/l). Samples were centrifuged for 10 min at 1,600 g and 4°C, and plasma was stored at -40°C for lactate analysis later.

Endurance exercise test. Before and immediately after each test, fasting free-flowing antecubital venous blood was collected in decapped K3EDTA-containing Monoject tubes (final concentration 1.5 g/l; Sherwood Medical, Ballymoney, Northern Ireland) and in heparin (final concentration 143 US Pharmacopea units/5 ml; Monoject tubes). Tubes were immediately closed, and blood and anticoagulant were carefully mixed. One tube with EDTA-anticoagulated blood was sent to Amsterdam (at ambient temperature) and was analyzed the next day for RBC deformability and plasma viscosity. Extensive pilot experiments demonstrated that such transport did not significantly affect RBC deformability (results not reported). EDTA-containing plasma was prepared by centrifugation (10 min, 1,300 g, 4°C). Part of the plasma was stored at -80°C for antioxidant analysis. RBCs were washed twice with EDTA-containing saline (28.64 g Na2EDTA · 2H2O/l, 7.00 g NaCl/l) and stored under nitrogen at -40°C for a maximum of 4 days.

Blood Analyses

Lactate. EDTA-containing plasma, collected during Wmax tests, was analyzed for lactate (enzymatic lactate dehydrogenase method; LDH no. 106984, Boehringer Mannheim, Mannheim, Germany) on a COBAS-BIO centrifugal analyzer (Hoffmann-La Roche).

Hematologic variables, RBC deformability, and plasma viscosity. Hematologic variables in EDTA-anticoagulated blood were analyzed on a Coulter counter (model MD 18, Miami, FL), and changes in blood and plasma volume during endurance exercise were calculated by using hematocrit (Hct) and hemoglobin (Hb) values (5).

RBC deformability was measured based on the ektacytometric principle using a laser-assisted optical rotational cell analyzer [(LORCA) R&R Mechatronics, Hoorn, The Netherlands] (11). Briefly, 25 µl of EDTA-anticoagulated blood were suspended in 5 ml of a 5% solution of polyvinylpyrrolidone (300 mosmol/l, Sigma Chemical, St. Louis, MO). This sample was then subjected to several rotational speeds at 21°C, giving final shear stresses ranging from 0.30 to 53.35 Pa. Laser diffraction was used to follow the change of the RBC population from biconcave toward an ellipsoid morphology under increased shear stress, and the deformability [elongation index (EI)] of the RBCs was calculated from the major and minor axis of the ellipsoid diffraction pattern (Fig. 1). Apart from the near-maximum values at a shear stress of 30 Pa as previously reported (29), we also evaluated the EI at 0.95, 3, and 9.5 Pa, because, for example, rigidification of RBC with glutaraldehyde decreases the EI only at lower shear stresses (12). The rest of the EDTA-containing blood was centrifuged for 10 min at 3,000 g and room temperature, and the viscosity of the plasma was measured in duplicate at a shear rate of 70/s by using a Contraves LS 30 viscometer (Contraves, Zürich, Switzerland).
Fig. 1. Change in diffraction pattern during elongation of red blood cells exposed to various shear stresses in vitro (log scale). Elongation index (EI) is calculated from major (A) and minor (B) axes of ellipsoid diffraction pattern.
[View Larger Version of this Image (13K GIF file)]

Phospholipid fatty acids. Phospholipids were extracted from the RBCs, and their fatty acids were methylated and analyzed by gas chromatography as described by Foreman-van Drongelen et al. (7), with the modification that fatty acids were separated on BPX70 polar and BP1 nonpolar capillary columns (Scientific Glass Engineering, Austin, TX). Fish oil from the capsules was directly methylated with triheptadecanoin as internal standard. The polyunsaturated fatty acid (PUFA) unsaturation index was calculated as the sum of the molar percentage of each PUFA (mol/mol total fatty acids · 100%) multiplied by its number of double bonds.

Plasma antioxidants. EDTA-containing plasma was analyzed for retinol, tocopherols, and carotenoids by HPLC with simultaneous absorbance and fluorescence detection as described by Hess et al. (13), with the modification that an internal standard (retinol acetate) was used, and extraction of lipids was performed twice to improve recovery. Fish oil capsules were dissolved (20 mg oil/ml) in ethanol-dioxane-acetonitrile (1:1:3, EDA) and were analyzed by HPLC. Chromatogram peak areas were calibrated against standards dissolved in EDA. Because pure phytofluene was not available, quantitative determination of this compound was not possible. beta -Tocopherol coeluted with gamma -tocopherol. The canthaxanthin standard eluted separately from the lutein standard, but in plasma samples canthaxanthin appeared as a shoulder on the lutein peak. Therefore, concentrations of lutein reported here may also include canthaxanthin.

alpha -Tocopherol (all racemic), gamma -tocopherol, beta -cryptoxanthin, lycopene, and beta -carotene standards were a generous gift from Hoffmann-La Roche. Lutein, retinol (all trans), delta -tocopherol, and alpha -carotene were obtained from Sigma Chemical, and canthaxanthin was obtained from Fluka Chemie (Bornem, Belgium). Retinyl acetate and all other chemicals were purchased from Merck (Darmstadt, Germany).

LDL isolation and oxidation. LDLs were isolated from fresh EDTA-containing plasma immediately after collection by short-run, single-spin, density-gradient ultracentrifugation. In a 4.9-ml OptiSeal polyallomer centrifuge tube (Beckman Instruments, Palo Alto, CA), 0.85 ml of a 0.49 g/ml potassium bromide solution and 1.52 ml of plasma were gently mixed with a spatula. This mixture was carefully overlayered with distilled water, containing 1 g/l Na2EDTA · 2H2O. The tube was then centrifuged for 1 h at 561,000 g by using a near-vertical tube rotor (NVT-90, Beckman Instruments) in an XL-80 ultracentrifuge (Beckman Instruments). The top 0.6 ml was removed, and the next 1.6 ml, containing LDLs, were collected. EDTA was removed from LDL samples by gel filtration, by using two PD-10 Sephadex G25-M gel filtration columns (Pharmacia, Roosendaal, The Netherlands) placed on top of each other and a nitrogen-purged mobile phase [phosphate-buffered saline (PBS); composition (in mmol/l): 9.61 Na2HPO4, 1.56 NaH2PO4, and 154 NaCl, pH 7.4]. The EDTA-free LDLs were kept under a nitrogen atmosphere to prevent oxidation and were analyzed for cholesterol content (Monotest cholesterol, Boehringer Mannheim).

Within 15 min after gel filtration, an aliquot of each sample was diluted in a quartz cuvette with PBS (not purged with nitrogen) to a final concentration of 0.26 mmol cholesterol/l, and oxidation was initiated with CuCl2 (final concentration 2 µmol/l). Oxidation of PUFAs at 37°C was measured spectrophotometrically by monitoring the formation of conjugated fatty acid dienes at 234 nm. The lag time before rapid formation of conjugated dienes was calculated from the intercept of linear lines through the point of maximum rate of diene formation and the absorbance immediately after addition of copper (6). In addition, the time at which the maximum rate of oxidation was reached (TRmax) was also determined. TRmax represents a combined effect of the lag time and the rate of oxidation.

Statistics

Effects of endurance exercise were examined before supplementation for all 24 subjects together by Student's paired two-tailed t-test. To evaluate the effects of the supplements, responses were calculated for each subject as the changes in exercise parameters and preendurance exercise biochemical values over the period of supplementation. Differences in responses between the three experimental groups were then compared by analysis of variance (ANOVA). The P group allowed us to correct for possible drifts with time. Differences between the experimental groups in changes during exercise after supplementation compared with changes during exercise before supplementation were also compared by ANOVA. The overall level of significance was set at P < 0.05. Because between-group ANOVA involved three simultaneous comparisons, between-group levels of significance were set to P < 0.017, according to the Bonferroni method. All statistical analyses were performed by using the Statistical Analysis System (SAS Institute, 1989). Values are reported as means ± SE.


RESULTS

Effects of Endurance Exercise Before Supplementation

Body weights were similar in all groups (P: 74.8 ± 8.0; F: 74.5 ± 6.3; FE: 71.6 ± 6.1 kg) throughout the study. During the presupplementation endurance exercise test, subjects lost on average 0.56 ± 0.07 kg (P <=  0.0001) of body weight and consumed on average 0.65 ± 0.06 liter of water.

Effect of endurance exercise on hematologic variables, RBC deformability, and plasma viscosity. During the presupplementation endurance exercise test, the average RBC concentration, total Hb, and Hct increased by 5.3-5.7%. White blood cell concentrations increased from 5.38 ± 0.16 × 109/l before exercise to 7.48 ± 0.29 × 109/l after exercise (P <=  0.0001). Platelet concentrations increased from 202 ± 7 × 109/l to 259 ± 10 × 109/l (P <=  0.0001). Blood volume decreased by 5.0 ± 0.6% during exercise and plasma volume by 9.0 ± 1.0%. RBC deformability decreased during exercise, but only the decrease in EI of 0.005 ± 0.002 (P = 0.035) or 1.6% at a shear rate of 3 Pa reached statistical significance. Plasma viscosity increased from 1.46 ± 0.02 mPa · s before exercise to 1.52 ± 0.02 mPa · s after exercise (P = 0.005).

Effect of endurance exercise on plasma antioxidants. Unadjusted plasma antioxidant concentrations increased during endurance exercise. After correction for the decrease in plasma volume in each subject, however, plasma antioxidant concentrations decreased significantly, except for retinol (Table 1). Total tocopherol concentrations decreased by 0.77 ± 0.28 µmol/l (P = 0.012) or 2.9 ± 1.1%, and total carotenoid concentrations decreased by 0.08 ± 0.02 µmol/l (P = 0.0008) or 4.5 ± 1.2%.

Table  1.   Effect of endurance exercise on plasma antioxidant concentrations and modification by fish oil and vitamin E supplementation
Before Supplementation
After Supplementation
Placebo
Fish oil
Fish oil + vitamin E
Preexercise (n = 24) Change* (n = 24) Preexercise (n = 8) Change* (n = 8) Preexercise (n = 8) Change* (n = 8) Preexercise (n = 8) Change* (n = 8)

Retinol 1.82 ± 0.06  0.004 ± 0.020  1.77 ± 0.11   -0.043 ± 0.026  2.09 ± 0.09  0.011 ± 0.025  1.83 ± 0.11  0.031 ± 0.016 
Tocopherols 25.1 ± 1.0   -0.77 ± 0.28dagger 26.4 ± 2.2   -1.29 ± 0.52  27.1 ± 1.7   -0.26 ± 0.23  36.4 ± 2.6   -0.17 ± 0.42 
  delta -Tocopherol 0.15 ± 0.01   -0.011 ± 0.004dagger 0.17 ± 0.03   -0.022 ± 0.009  0.18 ± 0.02   -0.015 ± 0.008  0.09 ± 0.01  0.000 ± 0.001 
  beta  + gamma -Tocopherol 2.19 ± 0.19   -0.162 ± 0.035§ 2.79 ± 0.44   -0.283 ± 0.097  2.40 ± 0.30   -0.121 ± 0.028  0.75 ± 0.09   -0.026 ± 0.014 
  alpha -Tocopherol 22.7 ± 0.9   -0.60 ± 0.26dagger 23.4 ± 1.9   -0.98 ± 0.42  24.5 ± 1.6   -0.12 ± 0.22  35.5 ± 2.5   -0.15 ± 0.42 
Carotenoids 1.89 ± 0.10   -0.082 ± 0.021§ 1.92 ± 0.28   -0.111 ± 0.051  1.87 ± 0.12   -0.040 ± 0.036  1.73 ± 0.25   -0.028 ± 0.014 
  Lutein 0.51 ± 0.02   -0.026 ± 0.006§ 0.58 ± 0.06   -0.030 ± 0.009  0.55 ± 0.07   -0.016 ± 0.008  0.47 ± 0.03   -0.005 ± 0.006 
  beta -Cryptoxanthin 0.32 ± 0.02   -0.014 ± 0.005Dagger 0.31 ± 0.05   -0.015 ± 0.006  0.31 ± 0.03   -0.005 ± 0.007  0.30 ± 0.05   -0.003 ± 0.002 
  Lycopene 0.61 ± 0.06   -0.022 ± 0.007Dagger 0.62 ± 0.14   -0.044 ± 0.028  0.53 ± 0.05   -0.012 ± 0.011  0.47 ± 0.07   -0.007 ± 0.005 
  alpha -Carotene 0.07 ± 0.01   -0.003 ± 0.001Dagger 0.06 ± 0.01   -0.003 ± 0.002  0.07 ± 0.01   -0.001 ± 0.002  0.07 ± 0.02   -0.003 ± 0.001 
  beta -Carotene 0.38 ± 0.03   -0.017 ± 0.004§ 0.35 ± 0.04   -0.018 ± 0.008  0.41 ± 0.03   -0.006 ± 0.010  0.42 ± 0.14   -0.010 ± 0.005 
  Phytofluene 0.58 ± 0.07   -0.033 ± 0.009§ 0.65 ± 0.19   -0.060 ± 0.038  0.52 ± 0.04   -0.018 ± 0.012  0.46 ± 0.12   -0.014 ± 0.006

Values are means ± SE given in µmol/l plasma; n, no. of subjects. For phytofluene, chromatogram peak area is given (mV · min/µl plasma; amplification 100). Subjects performed a time trial of ~1 h on a cycle ergometer, before and after supplementation with placebo, fish oil (6 g/day), or fish oil (6 g/day) plus vitamin E (300 IU/day) for 3 wk. * Changes during exercise are adjusted for changes in plasma volume in each subject. Before supplementation, changes during exercise were examined by Student's paired t-test: dagger P < 0.05,  Dagger P < 0.01,  § P < 0.001. After supplementation, changes during exercise in the 3 groups were compared by analysis of variance, but no significant differences in changes were noticed between groups.

Effect of endurance exercise on LDL oxidation in vitro. The lag time before onset of rapid oxidation of LDL in vitro, the maximum rate of oxidation, and the TRmax were not affected by endurance exercise. The maximum amount of conjugated dienes formed in vitro decreased by 2.1 ± 1.0 µmol/mmol LDL cholesterol (P = 0.042) during the presupplementation endurance exercise test (Table 2).

Table  2.   Effect of endurance exercise on oxidation of LDL in vitro and modification by fish oil and vitamin E supplementation
Before Supplementation
After Supplementation
Placebo
Fish oil
Fish oil + vitamin E
Preexercise (n = 24) Change* (n = 24) Preexercise (n = 8) Change* (n = 8) Preexercise (n = 8) Change* (n = 8) Preexercise (n = 8) Change* (n = 8)

Lag time, min 66.4 ± 1.8   -0.5 ± 0.9  65.3 ± 3.5  3.4 ± 1.9  59.7 ± 2.0   -0.1 ± 1.8  75.9 ± 4.0   -0.7 ± 1.8 
Rmax, µmol · mmol LDL cholesterol-1 · min-1 3.48 ± 0.08   -0.06 ± 0.05  3.48 ± 0.06   -0.02 ± 0.03  3.02 ± 0.10  0.13 ± 0.09  2.66 ± 0.09  0.02 ± 0.06 
TRmax, min 95.0 ± 2.1   -0.5 ± 1.1  94.0 ± 3.9  4.0 ± 1.9  93.0 ± 2.2   -0.9 ± 2.9  114.8 ± 5.0   -3.4 ± 2.9 
Dienes, µmol/mmol LDL cholesterol 157.8 ± 2.3   -2.1 ± 1.0dagger 156.6 ± 3.5   -1.1 ± 1.4  159.2 ± 4.0   -1.4 ± 0.6  162.1 ± 3.6   -3.9 ± 1.6

Values are means ± SE; n, no. of subjects. Subjects performed a time trial before and after supplementation (for details, see Table 1 and text). Low-density-lipoproteins [(LDLs) 0.26 mmol cholesterol/l] were oxidized in vitro with 2 µmol CuCl2/l at 37°C, and formation of conjugated dienes was monitored spectrophotometrically at 234 nm. Lag time, time before onset of rapid oxidation; Rmax, maximum rate of diene formation; TRmax, time at which maximum rate was reached; dienes, amount of conjugated dienes formed. * Before supplements, changes during exercise were examined by Student's paired t-test: dagger P < 0.05. After supplements, changes during exercise in the 3 groups were compared by analysis of variance, but no significant differences in changes were noticed between groups.

Effects of Fish Oil and Vitamin E Supplementation

Effect of supplements on RBC phospholipid fatty acids. Compliance with the fish oil supplements was confirmed by an increase in the concentration of (n-3) PUFA in RBCs from 5.2 to 7.0 g/100 g of fatty acid in the F group (P <=  0.0001 vs. P) and from 5.2 to 7.6 g/100 g in the FE group (P <=  0.0001 vs. P) during the study (Table 3). The increase in EPA was larger in the FE group (P = 0.001 vs. F), but other indicators of compliance, such as changes in DHA and intake of capsules, were similar. Although increases in (n-3) PUFAs were accompanied by decreases in (n-6) PUFAs, the degree of PUFA unsaturation was significantly increased after supplementation with fish oil (Table 3).

Table  3.   Fatty acid composition of fish oil concentrate and effects of fish oil supplementation on fatty acid composition of red blood cell phospholipids
Fish Oil Concentrate Red Blood Cell Phospholipid Fatty Acids in Experimental Groups
Placebo
Fish oil
Fish oil + vitamin E
Baseline Change Baseline Change Baseline Change

Total saturates 25.9 47.9 ± 0.3   -0.4 ± 0.2  47.4 ± 0.2  0.2 ± 0.2  47.7 ± 0.3   -0.2 ± 0.3 
Total monoenes 26.5 17.8 ± 0.2   -0.1 ± 0.2  18.2 ± 0.4   -0.2 ± 0.1  17.7 ± 0.3   -0.1 ± 0.1 
Total polyenes 39.7 33.5 ± 0.2  0.4 ± 0.1  33.4 ± 0.4  0.2 ± 0.1  33.7 ± 0.2  0.2 ± 0.2 
  (n-6) Polyenes 3.8 28.4 ± 0.2  0.3 ± 0.1  28.0 ± 0.4   -1.7 ± 0.2Dagger 28.3 ± 0.5   -2.1 ± 0.3Dagger
    C18:2 (n-6) 1.2 12.4 ± 0.4  0.2 ± 0.2  12.2 ± 0.3   -0.7 ± 0.2dagger 13.2 ± 0.4   -1.3 ± 0.2Dagger
    C20:4 (n-6) 1.1 10.7 ± 0.2  0.1 ± 0.1  10.4 ± 0.2   -0.5 ± 0.1Dagger 10.0 ± 0.3   -0.3 ± 0.1dagger
  (n-3) Polyenes 35.7 4.9 ± 0.2  0.0 ± 0.1  5.2 ± 0.2  1.8 ± 0.1Dagger 5.2 ± 0.3  2.4 ± 0.1Dagger ,§
    C20:5 (n-3) 17.6 0.5 ± 0.1  0.0 ± 0.0  0.5 ± 0.1  0.8 ± 0.1Dagger 0.5 ± 0.1  1.2 ± 0.1Dagger ,§
    C22:6 (n-3) 12.5 2.4 ± 0.2  0.0 ± 0.0  2.6 ± 0.1  0.7 ± 0.1Dagger 2.8 ± 0.2  0.8 ± 0.0Dagger
Unidentified 7.9 1.0 ± 0.1  0.1 ± 0.1  1.0 ± 0.1  0.0 ± 0.1  1.0 ± 0.1  0.1 ± 0.1 
Polyene unsaturation index* 102.1 ± 0.9  0.9 ± 0.5  102.4 ± 0.8  3.5 ± 0.6dagger 102.0 ± 0.6  5.3 ± 0.4Dagger

Values are means ± SE given in g/100 g fatty acids for 24 subjects. Subjects received a placebo, fish oil (6 g/day), or fish oil (6 g/day) plus vitamin E (300 IU/day) supplement to their habitual diets for 3 wk. * Calculated as sum of percentage of each polyene (mol/mol total fatty acids · 100%) multiplied with its no. of double bonds. Changes after supplementation in 3 groups were compared by analysis of variance: significant difference from change in placebo group, dagger P < 0.01,  Dagger P <=  0.0001; § significant difference from change in fish oil group, P < 0.01.

Effect of supplements on Wmax. Prestratification by Wmax at the start of the study resulted in similar values of 5.0 ± 0.2, 4.9 ± 0.2, and 5.0 ± 0.2 W/kg in the P, F, and FE groups, respectively. During the study, Wmax slightly improved in all groups (0.12 W/kg or 2.5%), but no significant differences between the groups were noticed.

At the start of the study, mean maximal oxygen consumption (VO2 max) during the test was 4.4 ± 0.1 l/min, and it did not differ significantly between the groups. After supplementation, VO2 max increased by 0.01 ± 0.09 l/min in the P group, by 0.13 ± 0.13 l/min in the F group, and by 0.15 ± 0.09 l/min in the FE group. However, these changes were not significantly different between the groups (P > 0.3). Lactate concentrations at various workloads during the Wmax test, before and after supplementation, were also similar.

Effect of supplements on endurance exercise performance. The average time to complete the endurance exercise test at the start of the study was 55.9 ± 0.6 min (n = 24). After supplementation, performances were similar in all groups and changed by only 0.11 ± 0.49, -0.23 ± 1.35, and -0.07 ± 1.16 min in the P, F, and FE groups, respectively (P > 0.8 between groups).

Effect of supplements on hematologic variables, RBC deformability, and plasma viscosity. After supplementations, RBC concentrations, Hb, Hct, RBC deformability, and plasma viscosity, as well as their changes during exercise, were similar in the three experimental groups.

Effect of supplements on plasma antioxidants. Before supplementation, plasma antioxidant concentrations were similar in the three experimental groups and were similar to values previously observed in sedentary subjects (not shown). Fish oil supplementation alone did not significantly affect plasma antioxidant concentrations. Intake of the vitamin E capsules in the FE group was verified by an increase in the plasma alpha -tocopherol concentration from 20.0 ± 1.0 to 35.5 ± 2.5 µmol/l (P <=  0.0001 vs. other groups). This was accompanied by a significant decrease in beta +gamma -tocopherol from 1.93 ± 0.25 to 0.75 ± 0.09 µmol/l (P < 0.004 vs. other groups).

Decreases in plasma antioxidant concentrations during endurance exercise were smaller after fish oil and fish oil and vitamin E supplementation than were exercise-induced decreases after P supplementation (Table 1). However, differences between the groups did not reach statistical significance.

Effect of supplements on LDL oxidation in vitro. Before supplementation, LDL oxidation parameters were similar in all three groups. At the end of the supplementation period, the lag time tended to increase in the FE group compared with the other groups (P = 0.052 vs. F; P = 0.113 vs. P; Fig. 2). The rate of oxidation in vitro decreased by 0.52 ± 0.16 µmol dienes · mmol LDL cholesterol-1 · min-1 in the F group (P = 0.010 vs. P) and by 0.82 ± 0.18 µmol dienes · mmol LDL cholesterol-1 · min-1 in the FE group (P = 0.0003 vs. P; P = 0.159 vs. F), whereas the P group showed a slight increase (0.07 ± 0.08 µmol dienes · mmol LDL cholesterol-1 · min-1; Fig. 2). TRmax remained unchanged in the P and F groups but increased significantly in the FE group (change: 15.0 ± 5.7 min; P = 0.007 vs. P; P = 0.040 vs. F; Fig. 2). The maximum amount of dienes formed in vitro did not change significantly during the study, and no differences were, therefore, noticed between the groups (Fig. 2).
Fig. 2. Effect of placebo (open bars), fish oil (solid bars), and fish oil plus vitamin E (hatched bars) supplementation on copper-catalyzed oxidation of low-density lipoproteins (LDLs) in vitro. Values are changes (means ± SE) after 3 wk of supplementation. Lag times and time of maximum rate (TRmax) are expressed in min, maximum rate of oxidation (Rmax) in µmol · mmol LDL cholesterol-1 · min-1, and maximum amount of conjugated dienes in µmol/mmol LDL cholesterol. Significant differences from change in placebo group (by analysis of variance): * P <=  0.01; ** P < 0.001.
[View Larger Version of this Image (18K GIF file)]

After supplementation, changes in parameters of LDL oxidation during exercise, if any, did not differ significantly between the groups (Table 2).


DISCUSSION

The present study examined the effects of fish oil and vitamin E supplementation on exercise performance, RBC deformability, plasma antioxidant status, and in vitro LDL oxidation.

Effects of Endurance Exercise Before Supplementation

Effect of endurance exercise on hematologic variables, RBC deformability, and plasma viscosity. During endurance exercise, hemoconcentration of ~5% was observed, which was caused by a 9% reduction of the plasma compartment. At the same time, RBC deformability decreased at 3 Pa but not at 30 Pa, as reported by Van der Brug et al. (29) after their subjects performed a combination of cycling and running for 140 min. After a marathon, whole blood filterability was also impaired (8). Others, however, did not find a decrease in RBC filterability after a marathon (20). Guezennec et al. (9) observed a decrease in RBC filterability during a 1-h cycling exercise at a simulated altitude of 3,000 m in a hypobaric chamber but not at sea level. Although a decrease in RBC deformability is usually reported after longer exercises, the sensitive and reproducible LORCA technique (12) used in this study also detected a decrease after a 1-h time trial.

In the present study, the change in RBC deformability was small (<2%), but together with the 4.2% increase in plasma viscosity it may have a significant effect on whole blood viscosity, as previously demonstrated (29).

Effect of endurance exercise on plasma antioxidants. Plasma tocopherol and carotenoid concentrations, adjusted for hemoconcentration, decreased during exercise. Indirectly, this may indicate increased lipid peroxidation. After 45 min of running (18) or 90 min of submaximal cycling (30), no changes in plasma vitamin E were reported. Data from the latter study, however, were not adjusted for hemoconcentration, and a decrease in plasma vitamin E is, therefore, conceivable. Measurements of blood reduced and oxidized glutathione after submaximal cycling also indicated increased oxidative stress, but this was insufficient to cause damage to RNA (30).

On the other hand, another explanation for the decreased antioxidant concentrations is possible. Exercise-activated lipoprotein lipase (27) may have caused a transfer of tocopherols (15), and maybe also of carotenoids, from the circulation to tissues. This might also explain why plasma concentrations of retinol, which is mainly transported via a specific retinol binding protein, and much less via lipoproteins, did not decrease during exercise. However, others showed that, in muscle tissue, vitamin E concentrations also decrease after exercise (18).

Effect of endurance exercise on LDL oxidation in vitro. LDL oxidation in vitro was little affected by endurance exercise. The amount of conjugated dienes formed in vitro decreased slightly after exercise, and theoretically this indicates that the relative amounts of PUFAs in the native LDLs had decreased (22). This agrees with results of Sumikawa et al. (24), who showed that exercise decreased the proportion of PUFAs in RBC phospholipids of untrained subjects.

Effects of Fish Oil and Vitamin E Supplementation

Effect of supplements on exercise performance. Exercise performance, as measured by validated exercise tests, was not significantly altered by fish oil or fish oil and vitamin E supplementation in the present study. The Wmax slightly increased during the study in all groups. This small increase, however, was insufficient to improve endurance performance during the time trial. Nor were effects of fish oil supplementation on Wmax or VO2 max found in sedentary subjects (1). In well-trained subjects, Leaf and Rauch (17) found an increase in VO2 max (predicted VO2 max, based on treadmill performance) after daily supplementation with 6 g of fish oil, but no increase in VO2 max was noticed after supplementation with 12 g/day, and neither supplement improved treadmill performance.

Effect of supplements on RBC deformability. The ~2 g/100 g increase in (n-3) PUFAs in membrane phospholipids of RBC after fish oil supplementation did not affect RBC deformability. Results from other studies are conflicting. Earlier studies showed that supplementation with ~3.5 g/day of EPA (4) or fish oil (28) for 4-6 wk increases RBC (4) and whole blood (28) filterability, but no control groups were used. Guezennec et al. (9) reported that in trained subjects compared with nonsupplemented trained controls, daily supplementation with 2 g of fish oil for 6 wk improved filterability of washed RBCs after hypoxic exercise. Preexercise RBC filterability, however, was not improved by the supplement (9). A dose-response study also showed no effect of supplementation with up to 6 g/day of (n-3) fatty acid ethyl ester for 12 wk on filterability of 10% RBC solutions (2). The latter studies, together with the present one, show that supplementation with fish oil in moderate quantities does not significantly affect RBC deformability. Although supplementation with large quantities might affect RBC deformability, this is probably not feasible in humans.

Effect of supplements on plasma antioxidants. Fish oil supplementation did not affect plasma antioxidant concentrations. A decrease in plasma antioxidant concentrations after fish oil supplementation has been reported (19), but this was not confirmed in the present study or by others (10). Additional vitamin E supplementation, however, increased plasma alpha -tocopherol and decreased plasma beta +gamma -tocopherol concentrations, as has been found by others (18).

Effect of supplements on LDL oxidation in vitro. The lag time during oxidation of LDL in vitro was not affected by fish oil supplementation and was only nonsignificantly increased by additional vitamin E supplementation. A previous study in sedentary male subjects (21) showed a larger increase in lag time after fish oil and vitamin E supplementation compared with a decrease in lag time in subjects who received fish oil supplementation without vitamin E. Recently, Suzukawa et al. (25) also found a decrease in lag time after fish oil compared with corn oil supplementation in drug-treated hypertensive subjects.

In the present study, both fish oil and fish oil and vitamin E supplementation reduced the rate of LDL oxidation in vitro. This not only was found in a previous study (21) but also was reported by Suzukawa et al. (25). The mechanism responsible for this decrease is unknown, however. The decrease in rate of oxidation in the F group hardly affected the TRmax. Additional vitamin E supplementation delayed oxidation of LDL, although the apparent difference with the F group was only of borderline significance.

Fish oil supplementation did not affect the amount of conjugated dienes formed during LDL oxidation in vitro, whereas a previous study (21) showed a 20% increase after supplementation with a similar amount of fish oil. In addition, the in vitro formation of thiobarbituric acid-reactive substances in LDL samples is also increased after fish oil supplementation (10, 25). Although the fast method of LDL preparation used in the present study was different from the time-consuming method in the previous one (21), comparison of the two methods in sedentary volunteers showed no significant difference in the amount of conjugated dienes formed in vitro (results not reported).

In conclusion, this study shows that a 1-h intense exercise decreases RBC deformability, causes consumption or a shift of plasma tocopherols and carotenoids, and decreases the formation of conjugated dienes during oxidation of LDL in vitro. Although these changes may suggest increased oxidative stress during exercise, the physiological meaning of these small changes need further investigation. Contrary to previous findings, no adverse effects of fish oil supplementation on parameters of lipid peroxidation were found. However, this study also shows that moderate fish oil supplementation does not significantly improve RBC deformability or physical performance.


ACKNOWLEDGEMENTS

This study was supported by a grant from the Isostar Sport Nutrition Foundation.


FOOTNOTES

Address for reprint requests: R. P. Mensink, Maastricht Univ., Dept. of Human Biology, PO Box 616, 6200 MD Maastricht, The Netherlands.

Received 13 May 1996; accepted in final form 23 April 1997.


REFERENCES

1. Ågren, J. J., H. Pekkarinen, H. Litmanen, and O. Hanninen. Fish diet and physical fitness in relation to membrane and serum lipids, prostanoid metabolism and platelet aggregation in female students. Eur. J. Appl. Physiol. 63: 393-398, 1991.
2. Blonk, M. C., H. J. Bilo, J. J. Nauta, C. Popp-Snijders, C. Mulder, and A. J. Donker. Dose-response effects of fish-oil supplementation in healthy volunteers. Am. J. Clin. Nutr. 52: 120-127, 1990[Abstract/Free Full Text].
3. Bruckner, G., P. Webb, L. Greenwell, C. Chow, and D. Richardson. Fish oil increases peripheral capillary blood cell velocity in humans. Atherosclerosis 66: 237-245, 1987[Medline].
4. Cartwright, I. J., A. G. Pockley, J. H. Galloway, M. Greaves, and F. E. Preston. The effects of dietary omega -3 polyunsaturated fatty acids on erythrocyte membrane phospholipids, erythrocyte deformability and blood viscosity in healthy volunteers. Atherosclerosis 55: 267-281, 1985[Medline].
5. Dill, D. B., and D. L. Costill. Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J. Appl. Physiol. 37: 247-248, 1974[Free Full Text].
6. Esterbauer, H., G. Striegl, H. Puhl, and M. Rotheneder. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic. Res. Commun. 6: 67-75, 1989[Medline].
7. Foreman-van Drongelen, M. M. H. P., A. C. van Houwelingen, A. D. M. Kester, C. E. Blanco, T. H. M. Hasaart, and G. Hornstra. Influence of feeding artificial-formula milks containing docosahexaenoic and arachidonic acids on the postnatal long- chain polyunsaturated fatty acid status of healthy preterm infants. Br. J. Nutr. 76: 649-667, 1996[Medline].
8. Galea, G., and R. J. L. Davidson. Hemorrheology of marathon running. Int. J. Sports Med. 6: 136-138, 1985[Medline].
9. Guezennec, C. Y., J. F. Nadaud, P. Satabin, and P. Lafargue. Influence of polyunsaturated fatty acid diet on the hemorrheological response to physical exercise in hypoxia. Int. J. Sports Med. 10: 286-291, 1989[Medline].
10. Harats, D., Y. Dabach, G. Hollander, M. Ben-Naim, R. Schwartz, E. M. Berry, O. Stein, and Y. Stein. Fish oil ingestion in smokers and nonsmokers enhances peroxidation of plasma lipoproteins. Atherosclerosis 90: 127-139, 1991[Medline].
11. Hardeman, M. R., P. T. Goedhart, J. G. G. Dobbe, and K. P. Lettinga. Laser-assisted optical rotational cell analyser (L.O.R.C.A.); I. A new instrument for measurement of various structural hemorheological parameters. Clin. Hemorheol. 14: 605-618, 1994.
12. Hardeman, M. R., P. T. Goedhart, and N. H. Schut. Laser-assisted optical rotational cell analyser (L.O.R.C.A.); II. Red blood cell deformability: elongation index versus cell transit time. Clin. Hemorheol. 14: 619-630, 1994.
13. Hess, D., H. E. Keller, B. Oberlin, R. Bonfanti, and W. Schüep. Simultaneous determination of retinol, tocopherols, carotenes and lycopene in plasma by means of high-performance liquid chromatography on reversed phase. Int. J. Vitam. Nutr. Res. 61: 232-238, 1991[Medline].
14. Jeukendrup, A., W. H. M. Saris, F. Brouns, and A. D. M. Kester. A new validated endurance performance test. Med. Sci. Sports Exerc. 28: 266-270, 1996[Medline].
15. Kayden, H. J., and M. G. Traber. Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. J. Lipid Res. 34: 343-358, 1993[Medline].
16. Keizer, H. A., H. Kuipers, G. van Kranenburg, and P. Geurten. Influence of liquid and solid meals on muscle glycogen resynthesis, plasma fuel hormone response, and maximal physical working capacity. Int. J. Sports Med. 8: 99-104, 1986.
17. Leaf, D. A., and C. R. Rauch. Omega-3 supplementation and estimated VO2 max: a double blind randomized controlled trial in athletes. Ann. Sport Med. 4: 37-40, 1988.
18. Meydani, M., W. J. Evans, G. Handelman, L. Biddle, R. A. Fielding, S. N. Meydani, J. Burrill, M. A. Fiatarone, J. B. Blumberg, and J. G. Cannon. Protective effect of vitamin E on exercise-induced oxidative damage in young and older adults. Am. J. Physiol. 264 (Regulatory Integrative Comp. Physiol. 33): R992-R998, 1993[Abstract/Free Full Text].
19. Nair, P. P., J. T. Judd, E. Berlin, P. R. Taylor, S. Shami, E. Sainz, and H. N. Bhagavan. Dietary fish oil-induced changes in the distribution of alpha -tocopherol, retinol, and beta -carotene in plasma, red blood cells, and platelets: modulation by vitamin E. Am. J. Clin. Nutr. 58: 98-102, 1993[Abstract/Free Full Text].
20. Neuhaus, D., C. Behn, and P. Gaehtgens. Haemorheology and exercise: intrinsic flow properties of blood in marathon running. Int. J. Sports Med. 13: 506-511, 1992[Medline].
21. Oostenbrug, G. S., R. P. Mensink, and G. Hornstra. Effects of fish oil and vitamin E supplementation on copper-catalysed oxidation of human low density lipoprotein in vitro. Eur. J. Clin. Nutr. 48: 895-898, 1994[Medline].
22. Reaven, P., S. Parthasarathy, B. J. Grasse, E. Miller, F. Almazan, F. H. Mattson, J. C. Khoo, D. Steinberg, and J. L. Witztum. Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humans. Am. J. Clin. Nutr. 54: 701-706, 1991[Abstract/Free Full Text].
23. Simchon, S., K.-M. Jan, and S. Chien. Influence of reduced red cell deformability on regional blood flow. Am. J. Physiol. 253 (Heart Circ. Physiol. 22): H898-H903, 1987[Abstract/Free Full Text].
24. Sumikawa, K., Z. Mu, T. Inoue, T. Okochi, T. Yoshida, and K. Adachi. Changes in erythrocyte membrane phospholipid composition induced by physical training and physical exercise. Eur. J. Appl. Physiol. 67: 132-137, 1993.
25. Suzukawa, M., M. Abbey, P. R. Howe, and P. J. Nestel. Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages. J. Lipid Res. 36: 473-484, 1995[Abstract].
26. Szygula, Z. Erythrocytic system under the influence of physical exercise and training. Sports Med. 10: 181-197, 1990[Medline].
27. Taskinen, M.-R., E. A. Nikkila, S. Rehunen, and A. Gordin. Effect of acute vigorous exercise on lipoprotein lipase activity of adipose tissue and skeletal muscle in physically active men. Artery 6: 471-483, 1980[Medline].
28. Terano, T., A. Hirai, T. Hamazaki, S. Kobayashi, T. Fujita, Y. Tamura, and A. Kumagai. Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects. Atherosclerosis 46: 321-331, 1983[Medline].
29. Van der Brug, G. E., H. P. F. Peters, M. R. Hardeman, G. Schep, and W. L. Mosterd. Hemorheological response to prolonged exercise; no effects of different kinds of feedings. Int. J. Sports Med. 16: 231-237, 1995[Medline].
30. Viguie, C. A., B. Frei, M. K. Shigenaga, B. N. Ames, L. Packer, and G. A. Brooks. Antioxidant status and indexes of oxidative stress during consecutive days of exercise. J. Appl. Physiol. 75: 566-572, 1993[Abstract/Free Full Text].

0161-7567/97 $5.00 Copyright © 1997 the American Physiological Society



This article has been cited by other articles:


Home page
J. Nutr.Home page
E. Theuwissen and R. P. Mensink
Simultaneous Intake of {beta}-Glucan and Plant Stanol Esters Affects Lipid Metabolism in Slightly Hypercholesterolemic Subjects
J. Nutr., March 1, 2007; 137(3): 583 - 588.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Cesari, S. B. Kritchevsky, B. J. Nicklas, B. W. H. J. Penninx, P. Holvoet, P. Koh-Banerjee, S. R. Cummings, T. B. Harris, A. B. Newman, and M. Pahor
Lipoprotein Peroxidation and Mobility Limitation: Results From the Health, Aging, and Body Composition Study
Arch Intern Med, October 10, 2005; 165(18): 2148 - 2154.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
R. P. Bogers, P. van Assema, A. D. M. Kester, K. R. Westerterp, and P. C. Dagnelie
Reproducibility, Validity, and Responsiveness to Change of a Short Questionnaire for Measuring Fruit and Vegetable Intake
Am. J. Epidemiol., May 1, 2004; 159(9): 900 - 909.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. Cesari, M. Pahor, B. Bartali, A. Cherubini, B. W. Penninx, G R. Williams, H. Atkinson, A. Martin, J. M Guralnik, and L. Ferrucci
Antioxidants and physical performance in elderly persons: the Invecchiare in Chianti (InCHIANTI) study
Am. J. Clinical Nutrition, February 1, 2004; 79(2): 289 - 294.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
I. Medved, M. J. Brown, A. R. Bjorksten, J. A. Leppik, S. Sostaric, and M. J. McKenna
N-acetylcysteine infusion alters blood redox status but not time to fatigue during intense exercise in humans
J Appl Physiol, April 1, 2003; 94(4): 1572 - 1582.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. P. Bogers, P. C. Dagnelie, K. R. Westerterp, A. D. M. Kester, J. D. van Klaveren, A. Bast, and P. A. van den Brandt
Using a Correction Factor to Correct for Overreporting in a Food-Frequency Questionnaire Does Not Improve Biomarker-Assessed Validity of Estimates for Fruit and Vegetable Consumption
J. Nutr., April 1, 2003; 133(4): 1213 - 1219.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. Park and S. B. Choi
Effects of {alpha}-tocopherol supplementation and continuous subcutaneous insulin infusion on oxidative stress in Korean patients with type 2 diabetes
Am. J. Clinical Nutrition, April 1, 2002; 75(4): 728 - 733.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. D. Toft, M. Thorn, K. Ostrowski, S. Asp, K. Moller, S. Iversen, C. Hermann, S. R. Sondergaard, and B. K. Pedersen
N-3 polyunsaturated fatty acids do not affect cytokine response to strenuous exercise
J Appl Physiol, December 1, 2000; 89(6): 2401 - 2406.
[Abstract] [Full Text] [PDF]